Home/Filings/4/0000950170-25-106028
4//SEC Filing

Doyle Mittie 4

Accession 0000950170-25-106028

CIK 0001789972other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 5:30 PM ET

Size

5.8 KB

Accession

0000950170-25-106028

Insider Transaction Report

Form 4
Period: 2025-08-07
Doyle Mittie
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-08-07+79,45679,456 total
    Exercise: $7.03Exp: 2035-08-07Common Stock (79,456 underlying)
Footnotes (1)
  • [F1]The option represents a right to purchase a total of 79,456 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date.

Documents

1 file

Issuer

Cullinan Therapeutics, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001918845

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 5:30 PM ET
Size
5.8 KB